IPO frenzy: Meesho, Aequs, Vidya Wires jointly attract ₹3 lakh crore bids on ₹6,642 crore offer

India’s primary market witnessed an extraordinary surge in investor interest this week as the initial public offerings (IPOs) of Meesho, Aequs, and Vidya Wires collectively attracted bids exceeding ₹3 lakh crore, against a combined issue size of ₹6,642 crore. The three IPOs—spanning consumer internet, precision manufacturing, and industrial wire solutions—saw heavy oversubscription across categories.

Aequs led in overall subscription at 101.63×, followed by Meesho at 79×, while Vidya Wires drew 26.59× bids. Notably, Meesho alone accounted for nearly 80% of total bid value across the three issues.

Meesho’s ₹5,421 crore IPO, priced at ₹105–₹111 per share, received bids worth ₹2.42 lakh crore, with more than 2,196 crore shares bid against just 27.79 crore shares on offer. The issue saw overwhelming institutional participation, with the QIB segment subscribed 120.18×, contributing bids worth ₹2,00,596 crore. The NII segment subscribed 39.85×, adding ₹32,409 crore, while retail investors subscribed 19.89×, bidding over 97 crore shares valued at ₹10,783 crore.

Ahead of the launch, Meesho had raised ₹2,439 crore through its anchor book.

Aequs also recorded strong traction, receiving bids worth ₹50,401 crore for its ₹922 crore public issue, priced at ₹118–₹124 per share. Institutional investors once again dominated, with the QIB segment subscribed 121×, generating bids of ₹32,262 crore. The NII category attracted 80.6× subscription worth ₹10,976 crore, while retail bidders subscribed 78×, contributing ₹7,083 crore. The employee portion, too, saw solid interest at 36×. Before opening to the public, Aequs had secured ₹414 crore from anchor investors.

Vidya Wires’ ₹300 crore IPO, at an issue price of ₹48 per share, received bids worth ₹5,531 crore. The NII category led with 51× subscription, contributing ₹2,323 crore, while retail investors subscribed 28×, bidding ₹2,905 crore. The QIB portion was subscribed over 5×, adding ₹302 crore in bids. The company had earlier raised ₹90 crore through anchor investors.

All three IPOs opened for subscription between December 3 and 5. The allotment of shares is expected to be finalised on December 8, while the three companies are tentatively scheduled to list on the BSE and NSE on December 10.

Next week is also going to be action packed as four IPOs—including Wakefit Innovations and three healthcare-focused issues from Nephrocare Health Services, Park Medi World, and Corona Remedies—will open for subscription between December 8 and December 12, 2025. The four mainboard IPOs looks to collectively raise over ₹3,735 crore.

(DISCLAIMER: The views and opinions expressed by investment experts on fortuneindia.com are either their own or of their organisations, but not necessarily that of fortuneindia.com and its editorial team. Readers are advised to consult certified experts before taking investment decisions.)